An evaluation of practice pattern for venous thromboembolism prevention in Lebanese hospitals

Journal of Thrombosis and Thrombolysis

Volumn 28, Issue 2, 2009, Pages 192-199

  Zeitoun, Abeer A ^a   Dimassi, Hani I ^a   El Kary, Dania Y ^a   Akel, Marwan G ^a  

^a LEBANESE AMERICAN UNIVERSITY   (Lebanon)

Author keywords

American College of Chest Physicians (ACCP) guidelines; Appropriateness of VTE prophylaxis; Lebanese population; Medication use evaluation (MUE); Multi center design; VTE prophylaxis

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DEMOGRAPHY; DISEASE CONTROL; DRUG CONTRAINDICATION; DRUG DOSE REDUCTION; FEMALE; HOSPITAL CARE; HUMAN; INTENSIVE CARE UNIT; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; LEBANON; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; TEACHING HOSPITAL; TREATMENT DURATION; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; GUIDELINE ADHERENCE; HUMANS; LEBANON; MALE; MIDDLE AGED; NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROCESS ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 67849105045     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-008-0298-7     Document Type: Article

References (64)

1. Anderson FA Jr, Wheeler HB, Goldberg RJ et al (1992) The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med 152:1660-1664. doi: 10.1001/archinte.152.8.1660
2. Samama CM (2001) Venous thromboembolism deserves your attention. Crit Care 5:277-279. doi: 10.1186/cc1046
3. Hacking N, Hellewell A, Sadler P (2006) Prevention of deep vein thrombosis and pulmonary embolus. Anaesth Intensive Care Med 7(12):449-452. doi: 10.1053/j.mpaic.2006.09.010
4. White RH (2003) The epidemiology of venous thromboembolism. Circulation 107(23 Suppl 1):I4-I8
5. Alonso Ortiz del Rio C, Medrano Ortega FJ, Romero Alonso A, Villar Conde E, Calderon Sandubete E, Marin Leon I et al. Prevention of thromboembolic venous disease in medical patients. 1998-2007 National Guideline Clearinghouse
6. Scottish Intercollegiate Guidelines Network (SIGN) (2002) Prophylaxis of venous thromboembolism. A national clinical guideline. SIGN, Edinburgh, Scotland; Oct 2002, 47 p. SIGN publication, no. 62, [214 references]. 1998-2007 National Guideline Clearinghouse
7. Joint Commission on Accreditation of Healthcare Organizations/National Quality Forum (2004) Joint Commission, National Quality Forum to work on deep vein thrombosis prevention and care project, vol 85(3), pp 607-624
8. Marr WL (2006) Deep venous thrombosis recommendations. J Vasc Nurs 24(3):91-93. doi: 10.1016/j.jvn.2006.06.013
9. Geerts WH, Pineo GF, Heit JA et al (2004) Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126(3 Suppl):338S-400S. doi: 10.1378/ chest.126.3_suppl.338S
10. Geerts WH, Heit JA, Clagett GP et al (2001) Prevention of venous thromboembolism. Chest 119:132S-175S. doi: 10.1378/chest.119.1_suppl.132S
11. Mant M (2004) Clinical guide - DVT prophylaxis in orthopedics. The Thrombosis Interest Group of Canada. Home page at: http://www.tigc.org. Accessed April 2008
12. Anonymous (2007) Venous thromboembolism: Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients undergoing surgery. National Institute for Health and Clinical Excellence (NICE) clinical guideline 46
13. Gnanalingham KK (2003) Attitudes to the use of prophylaxis for thrombo-embolism in neurosurgical patients. J Clin Neurosci 10(4):467-469. doi: 10.1016/S0967-5868(03)00060-2
14. Hull RD, Pineo GF, Stein PD et al (2001) Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: A systematic review. Ann Intern Med 135:858-869
15. Koda-Kimble MA, Young LY, Kradjan WA, Guglielmo BJ, Alldredge BK, Corelli RL (2005) Applied therapeutics: The clinical use of drugs, 8th edn. Thrombosis Chap 16:1-25
16. Bates SM, Ginsberg JS (2004) Clinical practice. Treatment of deep-vein thrombosis. N Engl J Med 351:268-277. doi: 10.1056/NEJMcp031676
17. Caprini JA, Tapson VF, Hyers TM et al (2005) Treatment of venous thromboembolism: Adherence to guidelines and impact of physician knowledge, attitudes, and beliefs. J Vasc Surg 42(4):726-733. doi: 10.1016/j.jvs.2005.05.053
18. Brunto L, Lazo J, Parker K (2005) Goodman and Gilman's the pharmacological basis of therapeutics, 11th edn. Blood coagulation and anticoagulant, thrombolytic, and antiplatelet drugs. Chap 54, pp 1467-1486
19. Kleinbart J, Williams MV, Rask K. Chapter 31: Prevention of venous thromboembolism. Available online at: http://www.ahcpr.gov/clinic/ ptsafety/chap31a.htm. Accessed April 2008
20. Heit JA (2003) Risk factors for venous thromboembolism. Clin Chest Med 24:1-12. doi: 10.1016/S0272-5231(02)00077-1
21. Haas SK (2002) Venous thromboembolic risk and its prevention in hospitalized medical patients. Semin Thromb Hemost 28:577-584. doi: 10.1055/s-2002-36702
22. Risk assessment tool: Are you at risk for DVT? Illinois State Medical Society. Home page at: http://www.isms.org
23. McCaffrey R, Bishop M, Adonis-Rizzo M et al (2007) Development and testing of a DVT risk assessment tool: Providing evidence of validity and reliability. Worldviews Evid Based Nurs 4(1):14-20. doi: 10.1111/ j.1741-6787.2007.00074.x
24. The coalition to prevent deep venous thrombosis. DVT risk assessment tool. 2007 sanofi-aventis
25. Caprini JA, Arcelus JI, Reyna JJ (2001) Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol 38(2 Suppl 5):12-19. doi: 10.1053/shem.2001.25184
26. Second Thromboembolic Risk Factors (THRIFT II) Consensus Group (1998) Risk of and prophylaxis for venous thromboembolism in hospital patients. Phlebology 13:87-97
27. Thromboembolic Risk Factors (THRIFT) Consensus Group (1992) Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ 305:567-574
28. Aldrich D, Hunt DP (2004) When can the patient with deep venous thrombosis begin to ambulate? Phys Ther 84:268-273
29. Blättler W, Partsch H (2003) Leg compression and ambulation is better than bed rest for the treatment of acute deep venous thrombosis. Int Angiol 22:393-400
30. Partsch H (2001) Therapy of deep vein thrombosis with low molecular weight heparin, leg compression and immediate ambulation. Vasa - J Vascular Dis 30:195-204
31. Partsch H, Blättler W (2000) Compression and walking versus bed rest in the treatment of proximal deep venous thrombosis with low molecular weight heparin. J Vasc Surg 32:861-869. doi: 10.1067/ mva.2000.110352
32. Amaragiri SV, Lees TA (2000) Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev (1). doi: 10.1002/14651858.CD001484
33. Agu O, Hamilton G, Baker D (1999) Graduated compression stockings in the prevention of venous thromboembolism. Br J Surg 86(8):992-1004. doi: 10.1046/j.1365-2168.1999.01195.x
34. Francis CW (2007) Clinical practice. Prophylaxis for thromboembolism in hospitalized medical patients. N Engl J Med 356:1438-1444. doi: 10.1056/ NEJMcp067264
35. Leizorovicz A, Mismetti P (2004) Preventing venous thromboembolism in medical patients. Circulation 110:IV13-IV19. doi: 10.1161/ 01.CIR.0000150640.98772.af
36. Hull RD, Raskob GE, Gent M et al (1990) Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacement. JAMA 263:2313-2317. doi: 10.1001/jama.263.17.2313
37. Holzheimer RG (2004) Prophylaxis of thrombosis with low-molecular-weight heparin (LMWH). Eur J Med Res 9:150-170
38. Aventis (2004) Lovenox® (enoxaparin sodium injection) prescribing information. Aventis Pharmaceuticals Inc., Bridgewater, NJ
39. McGarry LJ, Stokes ME, Thompson D (2006) Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients. Thromb J 4:17. doi: 10.1186/1477-9560-4-17
40. Rydberg EJ, Westfall JM, Nicholas RA (1999) Low-molecular-weight heparin in preventing and treating DVT. Am Fam Physician 59(6):1607-1612
41. Baglin TP, Keeling DM, Watson HG; British Committee for Standards in Haematology (2006) Guidelines on oral anticoagulation (warfarin): Third edition - 2005 update. Br J Haematol 132(3):277-285. doi: 10.1111/ j.1365-2141.2005.05856.x
42. Horton JD, Bushwick BM (1999) Warfarin therapy: Evolving strategies in anticoagulation. Am Fam Physician 59(3):635-646
43. Spinler SA, Dobesh P (2005) Dose capping enoxaparin is unjustified and denies patients with acute coronary syndromes a potentially effective treatment. Chest 127:2288-2290. doi: 10.1378/chest.127.6.2288
44. Mitsuyasu RT (2004) Adjusting enoxaparin by weight for DVT prophylaxis. Medscape Crit Care 5(2). Available online at: http://www.medscape.com/ viewarticle/488078
45. Royal Darwin Hospital. Venous thromboembolism prophylaxis guidelines
46. Lacut K, Bressollette L, Le Gal G et al (2005) Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology 65(6):865-869. doi: 10.1212/01.wnl.0000176073.80532.a2
47. Bergqvist D, Agnelli G, Cohen AT et al (2002) Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 346:975-980. doi: 10.1056/NEJMoa012385
48. Kanaan AO, Silva MA, Donovan JL et al (2007) Meta-analysis of venous thromboembolism prophylaxis in medically ill patients. Clin Ther 29(11):2395-2405. doi: 10.1016/j.clinthera.2007.11.015
49. Cohen AT, Alikhan R (2001) Prophylaxis of venous thromboembolism in medical patients. Curr Opin Pulm Med 7:332-337. doi: 10.1097/ 00063198-200109000-00014
50. Ageno W, Turpie AG (2005) What's new for DVT prophylaxis for the medically ill. Dis Mon 51(2-3):194-199. doi: 10.1016/ j.disamonth.2005.03.015
51. Mismetti P, Laporte-Simitsidis S, Tardy B et al (2000) Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: A meta-analysis of randomised clinical trials. Thromb Haemost 83:14-19
52. Clagett GP, Anderson FA, Heit J et al (1995) Prevention of venous thromboembolism. Chest 108:313S-334S
53. Khouli H, Shapiro J, Pham VP et al (2006) Efficacy of deep venous thrombosis prophylaxis in the medical intensive care unit. J Intensive Care Med 21(6):352-358. doi: 10.1177/0885066606292880
54. Cook D, Meade M, Guyatt G et al (2004) Clinically important deep vein thrombosis in the intensive care unit: A survey of intensivists. Crit Care 8(3):R145-R152. doi: 10.1186/cc2859
55. Todi SK, Sinha S, Chakraborty A et al (2003) Utilisation of deep venous thrombosis prophylaxis in medical/surgical intensive care units. Indian J Crit Care Med 7(2):103-105
56. Geerts W, Cook D, Selby R et al (2002) Venous thromboembolism and its prevention in critical care. J Crit Care 17(2):95-104. doi: 10.1053/ jcrc.2002.33941
57. Geerts W, Selby R (2003) Prevention of venous thromboembolism in the ICU. Chest 124(Suppl 6):357S-363S. doi: 10.1378/chest.124.6_suppl.357S
58. Vincent J, Esteban A, Cook DJ et al (2000) Venous thromboembolism in the ICU: What is the epidemiology and what are the consequences? Update in Intensive Care Medicine, pp 45-50
59. Shorr AF, Jackson WL Jr (2005) Deep vein thrombosis in the intensive care unit: Underappreciated, understudied, and undertreated. J Crit Care 20(4):301-303. doi: 10.1016/j.jcrc.2005.08.003
60. Attia J, Ray JG, Cook DJ et al (2001) Deep vein thrombosis and its prevention in critically ill adults. Arch Intern Med 161(10):1268-1279. doi: 10.1001/archinte.161.10.1268
61. Marik PE, Andrews L, Maini B (1997) The incidence of deep venous thrombosis in ICU patients. Chest 111:661-664. doi: 10.1378/ chest.111.3.661
62. Rubin A, Dinan W, Klapholz A et al (2006) Assessment of adequacy of deep venous thrombosis (DVT) prophylaxis in patients with hospital-acquired DVT in a community teaching hospital; Cabrini Medical Center, New York, NY. Chest 130(4):259S
63. Masroujeh R, Shamseddeen W, Isma'eel H et al (2008) Underutilization of venous thromboemoblism prophylaxis in medical patients in a tertiary care center. J Thromb Thrombolysis 26:138-141. doi: 10.1007/ s11239-007-0084-y
64. Mazboudi O, Lababidi HM (2007) Current trends of prophylaxis for deep vein thrombosis in a tertiary care hospital in Lebanon. Chest 132:630S